Expansion of Access to Advanced Neuro-Robotic Care
Myomo, Inc., a leader in wearable medical robotics, has announced a significant expansion in patient access to its flagship device, the MyoPro® powered arm brace. This expansion comes through a new collaboration with Ottobock Care, a nationwide provider of prosthetic and orthotic clinical services.
Through this initiative, the MyoPro device will now be available across Ottobock Care clinics throughout the United States. The move is expected to substantially increase availability for individuals suffering from upper extremity impairments caused by neurological conditions such as stroke, brachial plexus injuries, and other disorders. By integrating this advanced robotic technology into clinical settings, both companies aim to improve functional recovery and overall quality of life for patients.
What the MyoPro Device Offers Patients
The MyoPro powered arm brace is a groundbreaking medical device designed to restore movement in weakened or paralyzed arms. Unlike traditional braces, the MyoPro uses non-invasive sensors to detect electrical signals generated by a patient’s muscles. These signals, known as electromyography (EMG) signals, allow the device to assist and amplify the user’s intended arm and hand movements.
This technology enables individuals to perform essential daily activities that may otherwise be impossible. Patients using the MyoPro have been able to feed themselves, carry objects, and complete routine household tasks independently. In many cases, users regain enough functionality to return to work and live more self-sufficient lives.
What makes the MyoPro particularly unique is that it is currently the only marketed device in the United States capable of restoring arm function through this type of EMG-based, non-invasive control system. Its innovative approach positions it as a key solution in the growing field of neuro-robotics and rehabilitation technology.
Role of Ottobock Care in Nationwide Deployment
Ottobock Care plays a central role in expanding access to the MyoPro device. With more than 50 patient care centers across the U.S., the organization is well-positioned to deliver advanced rehabilitation technologies to a broad patient base.
Ottobock Care has built a reputation for combining cutting-edge technology with personalized clinical services. Its team of certified clinicians works closely with patients, physicians, and therapists to develop tailored treatment plans. By adding the MyoPro to its portfolio, the organization is extending its capabilities beyond lower-limb solutions into upper-limb neuro-rehabilitation.
Kevin Heidenreich, Head of Patient Services at Ottobock Care, emphasized that the integration of MyoPro aligns with the company’s strategic vision. The organization has already been supporting patients with mobility challenges using devices like the C-Brace, a powered orthotic system for lower limbs. With the addition of MyoPro, Ottobock Care can now address a wider range of neurological impairments, including arm and hand paralysis.
Training and Clinical Integration Efforts
To ensure successful implementation, Myomo has been actively supporting Ottobock Care’s clinical teams. This includes comprehensive training programs for clinicians across various regions of the country. These training initiatives are designed to equip healthcare professionals with the knowledge and skills needed to properly evaluate, fit, and support patients using the MyoPro device.
The collaboration goes beyond simple product distribution. It represents a coordinated effort to integrate advanced robotics into clinical practice. By working closely with Ottobock Care specialists, Myomo aims to maintain high standards of patient care and maximize the effectiveness of its technology.
Early results from this partnership have been promising. Several patients have already been successfully fitted with the MyoPro device through Ottobock Care clinics. These individuals have experienced meaningful improvements in their ability to perform everyday tasks independently, highlighting the real-world impact of the technology.
Insurance Coverage and Patient Accessibility
One of the key factors enabling broader adoption of the MyoPro device is increasing insurance coverage. Medicare, along with a growing number of private health insurance providers, is now covering the cost of the device on a case-by-case basis. This development significantly reduces the financial barriers that have historically limited access to advanced rehabilitation technologies.
According to Myomo’s leadership, this shift in reimbursement policies is critical to addressing a large unmet need among patients with upper-limb paralysis. Many individuals who could benefit from the MyoPro have previously been unable to afford such solutions. Expanded insurance support, combined with wider clinical availability through Ottobock Care, is expected to bring this life-changing technology to a much larger population
About Ottobock Care’s Legacy and Expertise
Ottobock Care is part of the broader Ottobock organization, which has more than a century of experience in prosthetics and orthotics innovation. The company has established itself as a global leader in mobility solutions, consistently pushing the boundaries of what is possible in rehabilitation technology.
In the United States, Ottobock Care operates a network of patient care centers that deliver comprehensive services. These include prosthetics, orthotics, and advanced mobility solutions tailored to individual needs. The organization’s approach emphasizes both technological innovation and compassionate care, ensuring that patients receive not only cutting-edge devices but also personalized support throughout their rehabilitation journey.
By incorporating neuro-robotic solutions like the MyoPro, Ottobock Care continues to expand its capabilities and reinforce its position as a leader in modern rehabilitation.
About Myomo and Its Mission
Myomo, Inc. is dedicated to improving the lives of individuals with neurological disorders and upper-limb paralysis. Headquartered in Burlington, Massachusetts, the company develops and markets wearable robotic devices that enhance mobility and independence.
The MyoPro product line represents the core of Myomo’s offerings. Designed for patients affected by conditions such as stroke, traumatic brain injury, spinal cord injury, and neuromuscular diseases, the device provides a practical solution for restoring arm and hand function.
Myomo’s mission extends beyond product development. The company is focused on enabling patients to regain independence, reduce long-term care costs, and improve overall quality of life. Through ongoing innovation and strategic partnerships, Myomo aims to make advanced rehabilitation technology accessible to as many patients as possible.
Industry Challenges and Forward-Looking Considerations
While the partnership between Myomo and Ottobock Care represents a significant advancement, the company acknowledges several challenges that could impact future growth. These include securing consistent reimbursement from insurance providers, maintaining supply chain stability, and scaling operations to meet increasing demand.
Additionally, the company operates in a highly competitive and rapidly evolving industry. Success will depend on its ability to continue innovating, maintain regulatory approvals, and achieve widespread market acceptance of its products.
Forward-looking statements included in the announcement highlight that actual results may differ from expectations due to various factors, including economic conditions, regulatory changes, and operational risks. As with any emerging technology, ongoing research, development, and clinical validation will play a crucial role in shaping the future of wearable medical robotics.The collaboration between Myomo and Ottobock Care marks a major step forward in expanding access to advanced neuro-robotic rehabilitation solutions. By making the MyoPro device available through a nationwide network of clinics, the partnership addresses a critical gap in care for individuals with upper-limb impairments.
With increasing insurance coverage, strong clinical support, and proven patient outcomes, the MyoPro has the potential to transform the lives of many individuals living with paralysis. As both organizations continue to innovate and collaborate, the future of wearable medical robotics looks increasingly promising, offering new hope for improved mobility, independence, and quality of life.
Source link:https://www.businesswire.com/
